AzTrials
AzTrials

DysphagiaEDU-DISNCT04959877

Role of Health Education in the Semipresential Logopedic Treatment of the Patient With Oropharyngeal Dysphagia

An observational study of Dysphagia, run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

When reviewing the literature, the need to investigate the health education of patients with dysphagia and their family members / caregivers has been detected. Numerous articles mention or it can be inferred from them that an education or training has been carried out for the patient and caregivers, but the… Read more about this study

Who is it for?
Ages 18 to 99 years
Conditions the study is for
Dysphagia
What is being tested?
health education
How many people
20 participants
Where
1 siteSpain
Study dates
8 Jun 2021to Apr 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients diagnosed with oropharyngeal dysphagia who require speech therapy

Who may be able to join

  • People between 18 and 99 years old diagnosed by videofluoroscopy of oropharyngeal dysphagia and who are candidates for speech therapy treatment for this reason.
  • Knowledge of the language sufficient to understand the audiovisual material on health education available at: logopediasantpau.wordpress.com
  • Have the necessary technological tools to carry out the telematic processing (electronic device with Internet access and WhatsApp) and know how to use them or have a family member / direct caregiver with basic technological skills.
  • Signature of the informed consent

Who cannot join

  • Moderate or severe cognitive impairment already known from the medical history or evaluated with the MoCA test in the absence of a family member or caregiver.
  • Having undergone speech therapy treatment for oropharyngeal dysphagia in the last year.
  • Not signing the informed consent.

Trial locations and contacts

1 site in 1 country.

Helena Bascuñana Ambros, MD, PhD contact

932919000

hbascunana@santpau.cat

Spain1 site, 1 recruiting
  • Hospital de la santa creu i sant Pau

    Barcelona, 08041

    Helena Bascuñana, Dr, 932919000, hbascunana@santpau.cat

    Recruiting

Other trials in Spain

About this study

When reviewing the literature, the need to investigate the health education of patients with dysphagia and their family members / caregivers has been detected. Numerous articles mention or it can be inferred from them that an education or training has been carried out for the patient and caregivers, but the investigators have not found any that specifically focuses on this aspect of the intervention. Only in some Clinical Practice Guidelines is the need for health education included

Conditions
Dysphagia
Being tested
health education
Medical subject headings
Deglutition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • health educationBehavioural

    data collect / Telemedicine

Study groups in NCT04959877
Study groupRoleWhat they receive
1Patients diagnosed with oropharyngeal dysphagia who require speech therapy treatment for this reason and who have voluntarily opted for the blended treatment modality.
Receives: Behavioral: health education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dysphagia Severity Rating Scale

    Scale assessment by MBS ( 1 Non Oral - 7 Full oral intake)

    Measured: up to 1 year

  2. Functional oral intake scale

    Scale assessment (1nothing by mouth - 7 full oral intake)

    Measured: up to 1 year

  3. Penetration Aspiration Scale

    Scale Assessment by MBS (1 No airway penetration - 8 Airway aspiration, no cough)

    Measured: up to 1 year

  4. Bolus Residual Scale

    Scale Assessment by MBS (1 No residues - 6 Residue in Valleculae and posterior Pharyngeal wall and piriform sinus)

    Measured: up to 1 year

Secondary outcomes (1)
  1. SwalQOL

    Quality of life related to oropharyngeal dysphagia (11 Domains)

    Measured: Up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2021
  2. Study start8 Jun 2021
  3. Primary completionJan 2022 (estimated)
  4. Study completionApr 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04959877
Sponsor's protocol ID
IIBSP-EDU-2021-50
Acronym
EDU-DIS
Status last verified
Nov 2021
First submitted
20 Jun 2021
Last updated
29 Nov 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Dysphagia, run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Helena Bascuñana Ambros, MD, PhD (932919000, hbascunana@santpau.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dysphagia Severity Rating Scale (time frame: up to 1 year). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in